Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kai-Hou-Jian spray is a Traditional Chinese Medicine (TCM) product widely used in China for the treatment of upper respiratory and oral inflammatory conditions, including acute pharyngitis, acute tonsillitis, and stomatitis. It is manufactured by Guizhou Sanli Pharmaceutical. The formulation typically includes extracts from *Ardisia crenata*, *Sophora tonkinensis*, and *Menthol*. It exerts anti-inflammatory, analgesic, and antimicrobial effects, providing rapid relief for sore throat symptoms. A specific pediatric version, Kai-Hou-Jian spray (children's type), has been evaluated in multicenter clinical trials (such as ChiCTR2000031599) to confirm its safety and immediate analgesic efficacy in children aged 4–12 years.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kai-Hou-Jian spray.